04:35 PM EST, 03/07/2024 (MT Newswires) -- Richard Daniell, Executive Vice President, European Commercial, on March 05, 2024, sold 48,629 shares in Teva Pharmaceutical Industries ( TEVA ) for $657,240. Following the Form 4 filing with the SEC, Daniell has control over a total of 98,943 shares of the company, with 98,943 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/xslF345X03/ownership.xml

Price: 13.66, Change: -0.05, Percent Change: -0.36